Epratuzumab Side Effects Epratuzumab Phase III Epratuzumab Clinical Trials Embody Trial Immunomedics Veltuzumab Cd22 anti|CD22 Monoclonal Antibodies
|Source||Humanized (from mouse)|
|(what is this?)|
Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus (SLE). The manufacturers in August 2009 announced success in early trials against SLE.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|